Minli Chen

1.4k total citations
62 papers, 1.1k citations indexed

About

Minli Chen is a scholar working on Molecular Biology, Physiology and Complementary and alternative medicine. According to data from OpenAlex, Minli Chen has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Physiology and 11 papers in Complementary and alternative medicine. Recurrent topics in Minli Chen's work include Traditional Chinese Medicine Analysis (9 papers), Bee Products Chemical Analysis (5 papers) and Adipose Tissue and Metabolism (4 papers). Minli Chen is often cited by papers focused on Traditional Chinese Medicine Analysis (9 papers), Bee Products Chemical Analysis (5 papers) and Adipose Tissue and Metabolism (4 papers). Minli Chen collaborates with scholars based in China, United States and Taiwan. Minli Chen's co-authors include Yongming Pan, Lifeng Qi, Zirong Xu, Fuliang Hu, Qiyang Shou, Yajing Li, Hongzhuan Xuan, Zheng-Fu Xie, Quanxin Ma and Yun Ling and has published in prestigious journals such as Circulation, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Minli Chen

62 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minli Chen China 20 378 144 130 126 118 62 1.1k
Bing Han China 25 563 1.5× 66 0.5× 125 1.0× 92 0.7× 135 1.1× 78 1.6k
Vahid Nejati Iran 24 406 1.1× 241 1.7× 109 0.8× 139 1.1× 87 0.7× 83 1.4k
Adem Kara Türkiye 18 221 0.6× 128 0.9× 73 0.6× 111 0.9× 125 1.1× 67 1.1k
Chiu-Yuan Chen Taiwan 13 298 0.8× 76 0.5× 87 0.7× 173 1.4× 45 0.4× 16 871
Maher A. Kamel Egypt 24 318 0.8× 54 0.4× 97 0.7× 105 0.8× 204 1.7× 104 1.5k
Pejman Mortazavi Iran 20 254 0.7× 57 0.4× 131 1.0× 186 1.5× 144 1.2× 108 1.1k
Uraiwan Panich Thailand 17 402 1.1× 129 0.9× 57 0.4× 50 0.4× 75 0.6× 43 1.5k
Ronny Lesmana Indonesia 19 544 1.4× 167 1.2× 82 0.6× 99 0.8× 318 2.7× 177 1.7k
Su‐Kil Seo South Korea 24 600 1.6× 143 1.0× 76 0.6× 156 1.2× 137 1.2× 64 1.8k
Xuemei Zhang China 26 635 1.7× 41 0.3× 141 1.1× 118 0.9× 77 0.7× 66 1.6k

Countries citing papers authored by Minli Chen

Since Specialization
Citations

This map shows the geographic impact of Minli Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minli Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minli Chen more than expected).

Fields of papers citing papers by Minli Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minli Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minli Chen. The network helps show where Minli Chen may publish in the future.

Co-authorship network of co-authors of Minli Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Minli Chen. A scholar is included among the top collaborators of Minli Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minli Chen. Minli Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jialing, et al.. (2024). Reporting quality and risk of bias of randomized controlled trials of Chinese herbal medicine for multiple sclerosis. Frontiers in Immunology. 15. 1429895–1429895. 4 indexed citations
2.
Cai, Zhaowei, Yingying Fan, Yujie Ren, et al.. (2023). Dysregulation of Ceramide Metabolism Is Linked to Iron Deposition and Activation of Related Pathways in the Aorta of Atherosclerotic Miniature Pigs. Antioxidants. 13(1). 4–4. 10 indexed citations
3.
4.
Li, Yajing, Jiaojiao Chen, Quanxin Ma, et al.. (2023). Protective effects of GuanXinNing tablet (GXNT) on diabetic encephalopathy in zucker diabetic obesity (ZDF) rats. BMC Complementary Medicine and Therapies. 23(1). 385–385. 3 indexed citations
5.
Zhang, Yan, et al.. (2023). Guanxinning tablets improve myocardial hypertrophy by inhibiting the activation of MEK-ERK1/2 signaling pathway. Journal of Applied Biomedicine. 21(3). 137–149. 3 indexed citations
6.
Huang, Weidong, Feng Chen, Quanxin Ma, et al.. (2020). Ribosome biogenesis gene DEF/UTP25 is essential for liver homeostasis and regeneration. Science China Life Sciences. 63(11). 1651–1664. 12 indexed citations
8.
Liu, Yichen, Yufei Zheng, Minli Chen, et al.. (2019). Ethanol Extract of Chinese Propolis Attenuates Early Diabetic Retinopathy by Protecting the Blood–Retinal Barrier in Streptozotocin‐Induced Diabetic Rats. Journal of Food Science. 84(2). 358–369. 16 indexed citations
9.
Chen, Minli, et al.. (2018). Single nucleotide polymorphisms of IL-13 and CD14 genes in allergic rhinitis: a meta-analysis. European Archives of Oto-Rhino-Laryngology. 275(6). 1491–1500. 13 indexed citations
10.
Pan, Yongming, Jianqin Xu, Cheng Chen, et al.. (2018). Royal Jelly Reduces Cholesterol Levels, Ameliorates Aβ Pathology and Enhances Neuronal Metabolic Activities in a Rabbit Model of Alzheimer’s Disease. Frontiers in Aging Neuroscience. 10. 50–50. 25 indexed citations
11.
Cai, Yueqin, Jue Tu, Jianping Jiang, et al.. (2015). Medicinal effect and its JP2/RyR2-based mechanism of Smilax glabra flavonoids on angiotensin II-induced hypertrophy model of cardiomyocytes. Journal of Ethnopharmacology. 169. 435–440. 18 indexed citations
12.
Cai, Zhaowei, Haitao Xi, Yongming Pan, et al.. (2015). Effect of testosterone deficiency on cholesterol metabolism in pigs fed a high-fat and high-cholesterol diet. Lipids in Health and Disease. 14(1). 18–18. 40 indexed citations
13.
Chen, Minli, et al.. (2015). Fentanyl inhibits proliferation and invasion of colorectal cancer via β-catenin.. PubMed. 8(1). 227–35. 25 indexed citations
15.
Shou, Qiyang, Jue Tu, Jianping Jiang, et al.. (2013). Modulation effect of Smilax glabra flavonoids on ryanodine receptor mediated intracellular Ca2+ release in cardiomyoblast cells. Journal of Ethnopharmacology. 150(1). 389–392. 15 indexed citations
16.
Shou, Qiyang, Yongming Pan, Xiaoping Xu, et al.. (2012). Salvianolic acid B possesses vasodilation potential through NO and its related signals in rabbit thoracic aortic rings. European Journal of Pharmacology. 697(1-3). 81–87. 27 indexed citations
17.
Wang, Li, Yangliang Ye, Lili Fu, et al.. (2009). Pyrimidinyl-arylpropionic acid derivatives: viable resources in the development of new antineoplastic agents. Investigational New Drugs. 28(4). 472–481. 2 indexed citations
18.
Ye, Yangliang, Zhou Zhou, Yu Shen, et al.. (2009). Discovery of novel dual functional agent as PPARγ agonist and 11β-HSD1 inhibitor for the treatment of diabetes. Bioorganic & Medicinal Chemistry. 17(15). 5722–5732. 25 indexed citations
19.
Qi, Lifeng, Zirong Xu, & Minli Chen. (2006). In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. European Journal of Cancer. 43(1). 184–193. 122 indexed citations
20.
Chen, Wen‐Jer, Wen‐Ko Chiou, Yung-Hui Lee, Ming‐Yih Lee, & Minli Chen. (1998). Myo-electric behavior of the trunk muscles during static load holding in healthy subjects and low back pain patients. Clinical Biomechanics. 13(1). S9–S15. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026